The control of the consumer risk in the Ames assay

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Markus Neuhäuser
  • Ludwig A. Hothorn

Organisationseinheiten

Externe Organisationen

  • SOLVAY GmbH
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)363-367
Seitenumfang5
FachzeitschriftDrug Information Journal
Jahrgang31
Ausgabenummer2
PublikationsstatusVeröffentlicht - 30 Dez. 1997

Abstract

Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

The control of the consumer risk in the Ames assay. / Neuhäuser, Markus; Hothorn, Ludwig A.
in: Drug Information Journal, Jahrgang 31, Nr. 2, 30.12.1997, S. 363-367.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Neuhäuser, M & Hothorn, LA 1997, 'The control of the consumer risk in the Ames assay', Drug Information Journal, Jg. 31, Nr. 2, S. 363-367. https://doi.org/10.1177/009286159703100207, https://doi.org/10.15488/3052
Neuhäuser, M., & Hothorn, L. A. (1997). The control of the consumer risk in the Ames assay. Drug Information Journal, 31(2), 363-367. https://doi.org/10.1177/009286159703100207, https://doi.org/10.15488/3052
Neuhäuser M, Hothorn LA. The control of the consumer risk in the Ames assay. Drug Information Journal. 1997 Dez 30;31(2):363-367. doi: 10.1177/009286159703100207, https://doi.org/10.15488/3052
Neuhäuser, Markus ; Hothorn, Ludwig A. / The control of the consumer risk in the Ames assay. in: Drug Information Journal. 1997 ; Jahrgang 31, Nr. 2. S. 363-367.
Download
@article{0f1622fb03684f1ab19894419befc65e,
title = "The control of the consumer risk in the Ames assay",
abstract = "Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.",
keywords = "Ames assay, Consumer risk, Difference approach, Equivalence test procedures for ordered many-to-one designs",
author = "Markus Neuh{\"a}user and Hothorn, {Ludwig A.}",
year = "1997",
month = dec,
day = "30",
doi = "10.1177/009286159703100207",
language = "English",
volume = "31",
pages = "363--367",
number = "2",

}

Download

TY - JOUR

T1 - The control of the consumer risk in the Ames assay

AU - Neuhäuser, Markus

AU - Hothorn, Ludwig A.

PY - 1997/12/30

Y1 - 1997/12/30

N2 - Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.

AB - Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.

KW - Ames assay

KW - Consumer risk

KW - Difference approach

KW - Equivalence test procedures for ordered many-to-one designs

UR - http://www.scopus.com/inward/record.url?scp=0342437485&partnerID=8YFLogxK

U2 - 10.1177/009286159703100207

DO - 10.1177/009286159703100207

M3 - Article

AN - SCOPUS:0342437485

VL - 31

SP - 363

EP - 367

JO - Drug Information Journal

JF - Drug Information Journal

SN - 0092-8615

IS - 2

ER -